MN Services Vermogensbeheer’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-121,500
Closed -$49.4M 539
2023
Q4
$49.4M Sell
121,500
-4,400
-3% -$1.63M 0.45% 59
2023
Q3
$43.8M Buy
125,900
+3,200
+3% +$1.12M 0.42% 65
2023
Q2
$43.2M Sell
122,700
-3,500
-3% -$1.18M 0.4% 66
2023
Q1
$39.8M Buy
126,200
+2,800
+2% +$840K 0.41% 62
2022
Q4
$35.6M Sell
123,400
-18,400
-13% -$5.61M 0.4% 63
2022
Q3
$41.1M Sell
141,800
-7,800
-5% -$2.24M 0.43% 57
2022
Q2
$42.2M Sell
149,600
-37,100
-20% -$9.93M 0.39% 63
2022
Q1
$48.7M Sell
186,700
-11,700
-6% -$2.78M 0.32% 80
2021
Q4
$43.6M Buy
198,400
+4,800
+2% +$933K 0.26% 98
2021
Q3
$35.1M Buy
193,600
+2,900
+2% +$566K 0.22% 128
2021
Q2
$32.4M Buy
+190,700
New +$39.9M 0.25% 105
2020
Q4
$54.2M Buy
229,200
+4,400
+2% +$1.01M 0.38% 77
2020
Q3
$61.2M Buy
224,800
+3,900
+2% +$1.08M 0.48% 53
2020
Q2
$64.1M Buy
220,900
+2,200
+1% +$596K 0.55% 49
2020
Q1
$52M Sell
218,700
-13,800
-6% -$3.17M 0.58% 47
2019
Q4
$50.9M Buy
232,500
+5,900
+3% +$1.19M 0.43% 64
2019
Q3
$38.4M Buy
226,600
+95,537
+73% +$16.9M 0.36% 81
2019
Q2
$24M Buy
131,063
+87,100
+198% +$15.2M 0.28% 86
2019
Q1
$8.09M Buy
43,963
+600
+1% +$111K 0.09% 233
2018
Q4
$6.29M Buy
43,363
+2,500
+6% +$433K 0.1% 227
2018
Q3
$7.88M Buy
40,863
+1,100
+3% +$196K 0.18% 120
2018
Q2
$6.76M Hold
39,763
0.17% 139
2018
Q1
$6.48M Buy
39,763
+500
+1% +$81.7K 0.17% 138
2017
Q4
$4.9M Sell
39,263
-1,600
-4% -$237K 0.15% 153
2017
Q3
$6.21M Hold
40,863
0.16% 145
2017
Q2
$5.27M Buy
40,863
+34,248
+518% +$4.12M 0.14% 167
2017
Q1
$676K Buy
6,615
+279
+4% +$24.6K 0.13% 175
2016
Q4
$443K Hold
6,336
0.09% 250
2016
Q3
$553K Buy
6,336
+111
+2% +$10.5K 0.11% 215
2016
Q2
$482K Buy
6,225
+84
+1% +$7.26K 0.11% 213
2016
Q1
$428K Buy
+6,141
New +$555K 0.1% 233

Other funds holding VRTX